Tesla faces setbacks, Eli Lilly’s weight-loss pill could widen GLP-1 access worldwide, and egg prices surge in a business news roundup
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
AutomatedAge – News, Insights & Trends in Automation and AI
Focus on the application of automation technology in various fields
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.